Uniting Innovation, Law, and Strategy in RNA, Cell and Gene Therapy, and Regenerative Medicines

Join the brightest minds in RNA, cell and gene therapies, and regenerative medicine at ACI’s 3rd Annual Forum on Advanced Therapeutics.

This premier event brings together industry leaders to explore evolving market trends, regulatory frameworks, and IP strategies shaping the future of advanced therapeutics. From funding innovations and AI in drug discovery to navigating legal and compliance challenges, gain the insights you need to drive scientific advancements to global market success.

2025 CONFERENCE CHAIRS
Speaker

Derek Johnson

Managing Director and General Counsel
Portal Innovations

Speaker

Lulu Wang

Head of IP
Orna Therapeutics

2025 FDA Keynote Speaker
Speaker

Julie Tierney

Deputy Center Director, Center for Biologics Evaluation and Research
FDA

USPTO Interview
Speaker

Andrea Grossman

Legal Advisor
Office of Patent Legal Administration
USPTO

2025 Featured Speakers
Speaker

Christina M. Hartman

Senior Director, Government Affairs
Orchard Therapeutics

Speaker

Deirdre Parsons

VP Public Policy and Government Relations
Alnylam

Speaker

Jocelyn Ram

IP Counsel
The Broad Institute of MIT

Speaker

Chuck Sholtz

Vice President, Intellectual Property
Nutcracker Therapeutics

Speaker

Laurence Shumway

Vice President, Intellectual Property Counsel
Flagship Pioneering

Speaker

Olga Zimmerman

Director, Intellectual Property
Caribou Biosciences, Inc.

IN-HOUSE INSIGHTS FROM
  • AdaptImmune
  • Alnylam
  • Beam Therapeutics
  • Caribou Biosciences
  • The Broad Institute of MIT
  • Flagship Pioneering
  • Novo Nordisk
  • Nutcracker Therapeutics
  • Orchard Therapeutics
CLE Accreditation

Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation. Learn More

ABOUT THIS CONFERENCE

ACI’s Advanced Therapeutics Forum: Uniting Innovation, Law and Strategy in RNA, Cell and Gene Therapy, and Regenerative Medicines

American Conference Institute is pleased to present the 3rd Annual Forum on Advanced Therapeutics, where the brightest minds in RNA, cell and gene therapies, and regenerative medicine converge to shape the future of this rapidly evolving field.

Positioned at the critical juncture of innovation, commercialization, and compliance — this premier event is dedicated to unraveling the complex interplay of evolving market trends, dynamic regulatory frameworks, and critical intellectual property strategies.

Join us in Boston on March 19–20 in this collaborative endeavor to drive forward the most groundbreaking developments in advanced therapeutics, marrying scientific discovery with strategic business and legal acumen for global impact.

Attend to engage with leading industry thought leaders and legal pioneers who will illuminate the path from groundbreaking research to global market success. Here, we explore in-depth the nuances of funding methodologies, AI’s transformative role in drug discovery, and the intricacies of navigating the legal, regulatory and IP landscapes.

Related Conferences
Event Thumbnail Image
Event Thumbnail Image
Event Thumbnail Image